Latest filing published 06 Jul 2017 for Rein Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Sigma Emerging Markets Ltd.: trading record in brief
Sigma Emerging Markets Ltd. appears in our data through filings on Rein Therapeutics, Inc. shares, published by SEC (Form 4). Activity is concentrated on a single trading day, 5 July 2017, with 2 filings.
No open-market sale appears; the market trades are 1 purchase worth €2.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 6 July 2017, reports a transaction in Rein Therapeutics, Inc. The clock since the last published purchase (6 July 2017) now reads 3,413 days. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sigma Emerging Markets Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 233,086 sharesCommon StockSEC:0000899243-17-018013:0
- 190,000 shares@ US$15.00Common StockSEC:0000899243-17-018013:1Canonical exit: 3 Oct 2017 (T+90)
2 of 2 declarations
